Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seagen Inc (NQ: SGEN ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Seagen Inc < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > 3 Steal-of-a-Deal Stocks to Snap Up Right Now February 26, 2024 Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now. Via InvestorPlace Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment February 22, 2024 Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several... Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property Get Rich Quick with These 7 Growth Stocks to Buy Now February 20, 2024 Here are seven growth stocks to buy that will let you know by their price action if the current bull market is ready to expand. Via InvestorPlace 7 Dividend Stocks to Buy at a 52-Week Low February 12, 2024 Each of these dividend stocks has been down sharply in the last 12 months but has fundamental reasons that support a turnaround. Via InvestorPlace Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market February 01, 2024 Pfizer is in Wall Street's doghouse, but don't despair. At its current price, value seekers ought to relish the opportunity to buy PFE stock. Via InvestorPlace Looking Into Seagen's Recent Short Interest December 13, 2023 Via Benzinga Seagen Inc. (NASDAQ: SGEN) is a Leading Gainer in 12/12 Morning Trading December 12, 2023 Via Investor Brand Network What the Options Market Tells Us About Seagen December 11, 2023 Via Benzinga 3 Pharma Stocks Could Be the Pills Your Portfolio Needs January 18, 2024 These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations. Via InvestorPlace How To Earn $500 A Month From Pfizer Stock January 02, 2024 Pfizer Inc. (NYSE: PFE) shares closed almost flat on Friday, but lost around 44% during 2023. Via Benzinga Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023. Via Benzinga 3 Stocks That Are About to Get Absolutely Crushed December 14, 2023 These are a few different companies that are experiencing difficult times and that are expected to keep falling. Via InvestorPlace $100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today December 07, 2023 Via Benzinga If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,600 Today November 20, 2023 Via Benzinga Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast December 14, 2023 Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Pfizer, Inc. (NYSE: PFE), Via Benzinga Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years? December 14, 2023 Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen. Via The Motley Fool 3 Sleepy Stocks Ready to Wake up in 2024 December 13, 2023 Strong projected earnings growth makes these three stocks strong candidates for exceptional growth in 2024. Via InvestorPlace Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades' December 13, 2023 On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc (NYSE: SHAK) Via Benzinga Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints December 13, 2023 Pfizer's updated 2024 revenue figures, including Seagen, undercut the consensus target. Via Investor's Business Daily Why Is US Pharma Giant Pfizer Stock Trading Lower Today? December 13, 2023 Pfizer Inc (NYSE: PFE) provided its full-year 2024 guidance, which includes the expected financial impact from the Seagen Inc (NASDAQ: SGEN) transaction. Via Benzinga Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition December 12, 2023 Pfizer Inc (NYSE: PFE) Via Benzinga Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal December 12, 2023 SystImmune and Bristol Myers Squibb & Co (NYSE: BMY) Via Benzinga ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma December 10, 2023 From Seagen Inc. Via Business Wire 3 Blue-Chip Stocks Set to Make a Comeback in 2024 December 08, 2023 These are the blue-chip stocks to buy as they represent quality companies with a steady growth outlook and promising cash flow growth. Via InvestorPlace TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer December 06, 2023 From Seagen Inc. Via Business Wire ImmunoGen Stock Nearly Doubled On Thursday: What Happened? November 30, 2023 Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion. Via Talk Markets FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer November 30, 2023 From Seagen Inc. Via Business Wire Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love November 30, 2023 Buying stocks simple for their high dividend yields is risky but these are three stocks the elite love regardless. Via InvestorPlace The 7 Most Undervalued Sleeper Stocks to Buy Now: November 2023 November 19, 2023 Here are just a few of the most undervalued sleeper stocks investors may want to consider heading into the new year. Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session November 10, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.